{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:58:35Z","timestamp":1781650715168,"version":"3.54.5"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":45,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The combination of minimal change disease and solid tumors is uncommon, and its mechanism is often associated with immune disorders or metabolic abnormalities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>Here, we describe an 8-year-old girl who presented with nephrotic syndrome characterized by edema and proteinuria as the initial symptoms. Chest imaging incidentally revealed the presence of a chest mass. Subsequently, a PET\/CT scan ruled out the possibility of renal infiltration. Following surgical resection of the mass, pathological examination ultimately confirmed it as neuroblastoma. However, even after complete tumor resection, the nephrotic syndrome in the child did not show any relief. A kidney biopsy confirmed minimal change disease, and serum anti-nephrin antibodies were detected. After treatment with glucocorticoids, significant relief of edema, proteinuria, and hypoalbuminemia was observed in the short term.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>We report a case of newly diagnosed MCD associated with neuroblastoma. This rare case highlights the importance of integrating clinical manifestations, imaging, pathology, and anti-nephrin antibody testing to assist in diagnosis and treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12882-026-04995-x","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T13:17:01Z","timestamp":1776777421000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A causal link or coincidence? Anti-nephrin antibody-positive minimal change disease coexisting with neuroblastoma in a child"],"prefix":"10.1186","volume":"27","author":[{"given":"Han","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanlong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruochen","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"issue":"4","key":"4995_CR1","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.mcna.2023.03.006","volume":"107","author":"MJ Zabala Ramirez","year":"2023","unstructured":"Zabala Ramirez MJ, Stein EJ, Jain K. Nephrotic Syndrome for the Internist. Med Clin N Am. 2023;107(4):727\u201337.","journal-title":"Med Clin N Am"},{"issue":"1","key":"4995_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.pcl.2018.08.006","volume":"66","author":"CS Wang","year":"2019","unstructured":"Wang CS, Greenbaum LA. Nephrotic Syndrome. Pediatr Clin North Am. 2019;66(1):73\u201385.","journal-title":"Pediatr Clin North Am"},{"issue":"2","key":"4995_CR3","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1542\/pir.2020-001230","volume":"43","author":"E Rodriguez-Ballestas","year":"2022","unstructured":"Rodriguez-Ballestas E, Reid-Adam J. Nephrotic Syndrome. Pediatr Rev. 2022;43(2):87\u201399.","journal-title":"Pediatr Rev"},{"issue":"6","key":"4995_CR4","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3892\/mco.2020.2156","volume":"13","author":"X Yu","year":"2020","unstructured":"Yu X, Fan Z, Chen W, Wang Z. Lung cancer with nephrotic syndrome as a paraneoplastic syndrome: A case report. Mol Clin Oncol. 2020;13(6):86.","journal-title":"Mol Clin Oncol"},{"issue":"1","key":"4995_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s10689-024-00435-7","volume":"24","author":"MA de Jong","year":"2024","unstructured":"de Jong MA, Slingerland M, Hawinkels L, Nielsen M, Crobach A, de Jonge-Muller ESM, Rabelink AJ, Langers AMJ. Recurrent paraneoplastic nephrotic syndrome; insights from a Lynch syndrome patient with multiple malignancies. Fam Cancer. 2024;24(1):11.","journal-title":"Fam Cancer"},{"issue":"27","key":"4995_CR6","doi-asserted-by":"publisher","first-page":"e16236","DOI":"10.1097\/MD.0000000000016236","volume":"98","author":"T Fujii","year":"2019","unstructured":"Fujii T, Kawasoe K, Tonooka A, Ohta A, Nitta K. Nephrotic syndrome associated with ramucirumab therapy: A single-center case series and literature review. Medicine. 2019;98(27):e16236.","journal-title":"Medicine"},{"issue":"6","key":"4995_CR7","doi-asserted-by":"publisher","first-page":"413","DOI":"10.6004\/jnccn.2024.0040","volume":"22","author":"R Bagatell","year":"2024","unstructured":"Bagatell R, Park JR, Acharya S, Aldrink J, Allison J, Alva E, Arndt C, Benedetti D, Brown E, Cho S, et al. Neuroblastoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Cancer Network: JNCCN. 2024;22(6):413\u201333.","journal-title":"J Natl Compr Cancer Network: JNCCN"},{"issue":"1","key":"4995_CR8","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1002\/jcp.29842","volume":"236","author":"W Jin","year":"2021","unstructured":"Jin W, Zhang Y, Liu Z, Che Z, Gao M, Peng H. Exploration of the molecular characteristics of the tumor-immune interaction and the development of an individualized immune prognostic signature for neuroblastoma. J Cell Physiol. 2021;236(1):294\u2013308.","journal-title":"J Cell Physiol"},{"issue":"25","key":"4995_CR9","doi-asserted-by":"publisher","first-page":"7929","DOI":"10.3748\/wjg.v21.i25.7929","volume":"21","author":"W Han","year":"2015","unstructured":"Han W, Wang HM. Refractory diarrhea: A paraneoplastic syndrome of neuroblastoma. World J Gastroenterol. 2015;21(25):7929\u201332.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"4995_CR10","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/S0022-3468(79)80003-2","volume":"14","author":"HL Zheng","year":"1979","unstructured":"Zheng HL, Maruyama T, Matsuda S, Satomura K. Neuroblastoma presenting with the nephrotic syndrome. J Pediatr Surg. 1979;14(4):414\u20139.","journal-title":"J Pediatr Surg"},{"issue":"5","key":"4995_CR11","first-page":"e60089","volume":"16","author":"L Yu","year":"2024","unstructured":"Yu L, Wang J, Feng C, Huang G, Gu W, Xiong J, Mao J. A Child With Concomitant Neuroblastoma and IgA Nephropathy: A Case Report and Literature Review. Cureus. 2024;16(5):e60089.","journal-title":"Cureus"},{"issue":"11","key":"4995_CR12","doi-asserted-by":"publisher","first-page":"e29949","DOI":"10.1002\/pbc.29949","volume":"69","author":"H Du","year":"2022","unstructured":"Du H, Cai W. Opsoclonus-myoclonus syndrome associated with neuroblastoma: Insights into antitumor immunity. Pediatr Blood Cancer. 2022;69(11):e29949.","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"4995_CR13","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1681\/ASN.2021060794","volume":"33","author":"AJB Watts","year":"2022","unstructured":"Watts AJB, Keller KH, Lerner G, Rosales I, Collins AB, Sekulic M, Waikar SS, Chandraker A, Riella LV, Alexander MP, et al. Discovery of Autoantibodies Targeting Nephrin in Minimal Change Disease Supports a Novel Autoimmune Etiology. J Am Soc Nephrology: JASN. 2022;33(1):238\u201352.","journal-title":"J Am Soc Nephrology: JASN"},{"issue":"4","key":"4995_CR14","doi-asserted-by":"publisher","first-page":"103794","DOI":"10.1016\/j.ekir.2026.103794","volume":"11","author":"FE Hengel","year":"2026","unstructured":"Hengel FE, Beldi-Ferchiou A, Sakhi H, Liaukouskaya N, Dehde S, Karras A, Esteve E, Oniszczuk J, Le Gouvello S, Herrera-Marcos L, et al. Effect of Steroids on Anti-nephrin Autoantibodies and B cells in Minimal Change Disease. Kidney Int Rep. 2026;11(4):103794.","journal-title":"Kidney Int Rep"},{"key":"4995_CR15","doi-asserted-by":"crossref","unstructured":"Chung C, Boterberg T, Lucas J, Panoff J, Valteau-Couanet D, Hero B, Bagatell R, Hill-Kayser CE. Neuroblastoma. Pediatr Blood Cancer. 2021;68(Suppl 2):e28473.","DOI":"10.1002\/pbc.28473"},{"issue":"1","key":"4995_CR16","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s12882-024-03632-9","volume":"25","author":"S Liu","year":"2024","unstructured":"Liu S, Wan Y, Hu Z, Wang Z, Liu F. Nephrotic syndrome associated with solid malignancies: a systematic review. BMC Nephrol. 2024;25(1):215.","journal-title":"BMC Nephrol"},{"issue":"11","key":"4995_CR17","first-page":"e31545","volume":"14","author":"V Karakus","year":"2022","unstructured":"Karakus V, Atas U, Uzuntas S, Dere Y, Meteoglu I. A Rare Nephrotic Syndrome Related to Chronic Lymphocytic Leukemia: Focal Segmental Glomerulosclerosis. Cureus. 2022;14(11):e31545.","journal-title":"Cureus"},{"issue":"2","key":"4995_CR18","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1159\/000331211","volume":"4","author":"GM Poggi","year":"2011","unstructured":"Poggi GM, Fognani G, Cuzzubbo D, Liguori A, Resti M, Pela I. Neuroblastoma presenting with acute kidney injury, hyponatremic-hypertensive-like syndrome and nephrotic proteinuria in a 10-month-old child. Case Rep Oncol. 2011;4(2):400\u20135.","journal-title":"Case Rep Oncol"},{"key":"4995_CR19","doi-asserted-by":"crossref","unstructured":"Leung P, Pianta T, Langsford D, Tay HS, Cooke R. Minimal change disease following autologous stem cell transplant for Hodgkin lymphoma. BMJ Case Rep. 2025;18(1).","DOI":"10.1136\/bcr-2023-259306"},{"issue":"2","key":"4995_CR20","first-page":"222","volume":"21","author":"PH de Oliveira Filgueira","year":"2010","unstructured":"de Oliveira Filgueira PH, Vasconcelos LF, da Silva GB, Daher Ede F. Paraneoplastic syndromes and the kidney. Saudi journal of kidney diseases and transplantation: an official publication of the Saudi Center for Organ Transplantation. Saudi Arabia. 2010;21(2):222\u201331.","journal-title":"Saudi Arabia"},{"issue":"1","key":"4995_CR21","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.critrevonc.2008.08.003","volume":"70","author":"J Bacchetta","year":"2009","unstructured":"Bacchetta J, Juillard L, Cochat P, Droz JP. Paraneoplastic glomerular diseases and malignancies. Crit Rev Oncol\/Hematol. 2009;70(1):39\u201358.","journal-title":"Crit Rev Oncol\/Hematol"},{"issue":"4","key":"4995_CR22","doi-asserted-by":"publisher","first-page":"296","DOI":"10.5414\/CN107708","volume":"81","author":"Q Long","year":"2014","unstructured":"Long Q, Wu P, Jiang G, Zhu C. Minimal change nephrotic syndrome associated with invasive thymoma: a case report with literature review. Clin Nephrol. 2014;81(4):296\u2013301.","journal-title":"Clin Nephrol"},{"issue":"6","key":"4995_CR23","doi-asserted-by":"publisher","first-page":"e0198013","DOI":"10.1371\/journal.pone.0198013","volume":"13","author":"R Verma","year":"2018","unstructured":"Verma R, Venkatareddy M, Kalinowski A, Li T, Kukla J, Mollin A, Cara-Fuentes G, Patel SR, Garg P. Nephrin is necessary for podocyte recovery following injury in an adult mature glomerulus. PLoS ONE. 2018;13(6):e0198013.","journal-title":"PLoS ONE"},{"issue":"10","key":"4995_CR24","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/s41581-024-00873-7","volume":"20","author":"Z Cui","year":"2024","unstructured":"Cui Z, Zhao MH. Anti-nephrin autoantibodies: a paradigm shift in podocytopathies. Nat Rev Nephrol. 2024;20(10):639\u201340.","journal-title":"Nat Rev Nephrol"},{"issue":"5","key":"4995_CR25","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1007\/s10157-025-02645-4","volume":"29","author":"T Horinouchi","year":"2025","unstructured":"Horinouchi T, Nozu K, Iijima K. Genetic aspects of pediatric nephrotic syndrome and anti-nephrin antibodies. Clin Exp Nephrol. 2025;29(5):534\u201340.","journal-title":"Clin Exp Nephrol"},{"issue":"2","key":"4995_CR26","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s40620-015-0234-9","volume":"29","author":"A Pani","year":"2016","unstructured":"Pani A, Porta C, Cosmai L, Melis P, Floris M, Piras D, Gallieni M, Rosner M, Ponticelli C. Glomerular diseases and cancer: evaluation of underlying malignancy. J Nephrol. 2016;29(2):143\u201352.","journal-title":"J Nephrol"},{"issue":"1","key":"4995_CR27","doi-asserted-by":"publisher","first-page":"41","DOI":"10.5301\/jn.5000157","volume":"26","author":"F Assadi","year":"2013","unstructured":"Assadi F. Strategies to reduce the incidence of chronic kidney disease in children: time for action. J Nephrol. 2013;26(1):41\u20137.","journal-title":"J Nephrol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-026-04995-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-04995-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-04995-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:29:34Z","timestamp":1781648974000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-026-04995-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4995"],"URL":"https:\/\/doi.org\/10.1186\/s12882-026-04995-x","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]},"assertion":[{"value":"7 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The clinical study was conducted in accordance with the principles of the Declaration of Helsinki and approved by the Ethics Committee of the Children\u2019s Hospital of Nanjing Medical University (approval number: 202008056-1), and informed consent was obtained from all parents of the children.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of their clinical details and\/or clinical images was obtained from the legal guardian of the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"353"}}